Serclutamab (Anti-ERBB1 / EGFR / HER1)

Serclutamab (Anti-ERBB1 / EGFR / HER1) is a monoclonal antibody targeting epidermal growth factor receptor (EGFR). It can be used in research of advanced solid tumors for advanced glioblastoma. MW :150 KD.
Supplier Selleck Chemicals
Product # A3164
Sku # A3164-1mg*5
Pricing 1mg*5, $1690.00
Feedback